Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results

Rhea-AI Summary

Johnson & Johnson (NYSE: JNJ) will host a conference call on January 23rd to review fourth-quarter results. Joaquin Duato, Chairman and CEO, Joseph J. Wolk, Executive Vice President and Chief Financial Officer, and Jessica Moore, Vice President, Investor Relations will host the call. The webcast and presentation material will be accessible at Johnson & Johnson’s website. A replay of the webcast will be available. Telephone dial-in numbers are provided for both U.S. and international participants. The press release will be available the morning of the conference call. Please note the first-quarter date of Tuesday, April 16th, 2024.

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)-- Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:30 a.m. (Eastern Time) on Tuesday, January 23^rd to review fourth-quarter results. Joaquin Duato, Chairman and CEO, Joseph J. Wolk, Executive Vice President and Chief Financial Officer and Jessica Moore, Vice President, Investor Relations will host the call.

Investors and other interested parties can access the webcast/conference call in the following ways:

• The webcast and presentation material are accessible at Johnson & Johnson’s website www.investor.jnj.com. A replay of the webcast will be available approximately three hours after the conference call concludes.
• By telephone: for both “listen-only” participants and those financial analysts who wish to take part in the question-and-answer portion of the call, the telephone dial-in number in the U.S. is 877-869-3847. For participants outside the U.S., the dial-in number is 201-689-8261.
• A replay of the conference call will be available until approximately 12:00 a.m. on February 6^th. The replay dial-in number for U.S. participants is 877-660-6853. For participants outside the U.S., the replay dial-in number is 201-612-7415. The replay conference ID number for all callers is 13742660.
• The press release will be available at approximately 6:45 a.m. (Eastern Time) the morning of the conference call.
• Please refer to www.investor.jnj.com for a complete list of currently planned earnings webcast/conference calls. Please note the first-quarter date of Tuesday, April 16^th, 2024.

About Johnson & Johnson

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com/.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231211636150/en/

Media contact:

media-relations@its.jnj.com

Investor contact:

investor-relations@its.jnj.com

Source: Johnson & Johnson

FAQ

When will Johnson & Johnson host the conference call to review fourth-quarter results?

Johnson & Johnson will host the conference call on January 23rd.

Who will host the conference call for Johnson & Johnson?

Joaquin Duato, Chairman and CEO, Joseph J. Wolk, Executive Vice President and Chief Financial Officer, and Jessica Moore, Vice President, Investor Relations will host the call.

Where can investors access the webcast and presentation material for Johnson & Johnson's conference call?

The webcast and presentation material will be accessible at Johnson & Johnson’s website.

How can participants access the replay of the webcast for Johnson & Johnson's conference call?

A replay of the webcast will be available, and telephone dial-in numbers are provided for both U.S. and international participants.

When will the press release be available for Johnson & Johnson's conference call?

The press release will be available the morning of the conference call.

What is the date of the first-quarter for Johnson & Johnson?

The first-quarter date is Tuesday, April 16th, 2024.